Are Hidden Viruses Lurking in Your Pet's Vaccines? What You Need to Know
"New research reveals potential viral contaminants in animal vaccines and raw materials—learn how to protect your pet."
Infectious diseases remain a significant threat to both human and animal health worldwide. However, the development and widespread use of vaccines have dramatically reduced the impact of many of these diseases. Landmark achievements such as the eradication of smallpox and the near-elimination of polio underscore the power of effective vaccination programs. Current research focuses on making vaccines safer and more effective than ever before.
One of the biggest concerns regarding vaccine safety is the potential for contamination by adventitious viruses. These unwanted viruses can find their way into vaccines through the animal-derived raw materials used in their production, such as bovine serum and trypsin. Several incidents, including the detection of porcine circovirus and parvovirus in rotavirus vaccines and nodovirus in human papillomavirus vaccines, have heightened awareness of this risk.
Regulatory agencies and vaccine manufacturers are now increasing their scrutiny of vaccine banks, cell substrates, and vaccine batches. Traditional detection methods, as outlined in the U.S. Department of Agriculture’s 9CFR 113, are often time-consuming, expensive, and may not catch all potential contaminants. Polymerase Chain Reaction (PCR) technology offers a faster, more specific, and sensitive alternative for detecting viral genomes. Recent research has optimized multiplex and individual PCR assays to detect porcine and bovine viral genomes in commercial vaccines and animal-derived raw materials.
Testing Requires Method Control
Recent work by Achs et al. (2025) reported no excessive residual DNA in COVID-19 mRNA vaccines using four orthogonal approaches, and that work has been cited by regulatory authorities. A 2026 study examined PCR results from clinical samples, vaccination-site environmental samples, and vaccines during a series of diagnostic contamination events. Earlier research also documented contamination of commercial PCR primers and probes with oligonucleotides, showing how contamination can affect diagnostic specificity and underscoring the need for comprehensive quality management.
From PCR to Vaccine Safety Checks
The development of polymerase chain reaction, or PCR, has been compared with the development of the Internet because of its broad impact. PCR later became a major technique in bioscience, diagnostics, and forensic science, with technologies evolving from the original method. Separately, after SV40 contamination was discovered in polio vaccines, the U.S. government established testing requirements to verify that new lots of polio vaccines were free of SV40; most contamination was found in inactivated polio vaccine, though oral polio vaccine was also affected.
Why is Detecting Viral Contamination So Important?
Vaccine safety is paramount. Public confidence in vaccines is crucial for maintaining high vaccination rates and preventing outbreaks of infectious diseases. When people fear that vaccines might be contaminated, they may avoid vaccination, reducing herd immunity and potentially leading to the resurgence of diseases previously under control.
- Traditional Methods: Current methods for detecting adventitious viruses, like those described in 9CFR 113, are often laborious, costly, and time-consuming.
- Limitations: These traditional methods may not cover the exhaustive list of potential viral contaminants and primarily target viruses that infect bovine and porcine hosts, potentially overlooking zoonotic viruses.
- PCR Advantage: PCR assays offer a faster, more sensitive, and specific alternative for detecting viral genomes in vaccines and raw materials.
Recent Findings on Vaccine-Related Materials
A 2025 proteomics and peptidomics study of fetal bovine serum used for cell culture found 88 proteins that differed significantly between high-grade and low-grade products, while peptidomic profiling detected more than 200 differentially abundant native peptide sequences. A retrospective laboratory analysis reported that porcine circovirus type 1 material was unexpectedly detected in the oral live-attenuated human rotavirus vaccine Rotarix, made by GSK Vaccines in Belgium, in 2010. A 2014 paper described individual and multiplex PCR assays for detecting adventitious bovine and porcine viral genome contaminants in commercial vaccines and animal-derived raw materials.
Why PCR Results Need Context
Real-time PCR has generally replaced conventional PCR in many applications because of its speed, increased specificity, semiquantification, reduced workload, and lower carry-over contamination risk. However, a 2026 analysis challenged the methodology used by Achs et al. in a 2025 study that reported no excessive residual DNA impurities in COVID-19 mRNA vaccines. The analysis was presented as a methodological critique rather than a new experimental vaccine analysis, illustrating why conclusions about residual DNA depend on how testing methods are designed and interpreted.
Combining Quality-Control Methods
The United States Pharmacopeia is developing analytical methods for viral-vectored vaccine quality to support developers, manufacturers, regulatory agencies, and national control laboratories worldwide. Its stated goal is to create a shared understanding of viral-vectored vaccine quality attributes and help accelerate product development. In vaccine quality-control laboratories, alternative methods such as real-time PCR are gaining regulatory acceptance because they can provide faster results than traditional or compendial testing, while microbial enumeration, or bioburden testing, remains an in-process measure of manufacturing safety and performance.
The Future of Vaccine Safety
The detection of adventitious viral genomes in vaccines underscores the need for continuous improvement in quality control measures. Implementing robust testing protocols, refining regulatory guidelines, and exploring alternative, non-animal-derived materials are crucial steps in ensuring the safety and efficacy of vaccines. By staying informed and supporting advancements in vaccine technology, we can better protect both animal and human health.
The Challenge of dsRNA Contamination
A 2026 systemic evaluation identified double-stranded RNA contamination generated during in vitro transcription as a significant challenge for messenger RNA vaccines. The study framed this contamination as relevant to both vaccine efficacy and safety. This places control of dsRNA generated during in vitro transcription among the broader quality challenges associated with mRNA vaccine production.
When Vaccine Material Affects Testing
A 2022 report described contamination of oropharyngeal swabs obtained from vaccinators with SARS-CoV-2 vaccines and highlighted the possibility of false-positive results. A 2023 study developed a one-step RT-qPCR assay targeting the ORF1ab and N genes of SARS-CoV-2, along with the Vero gene, to identify false-positive results caused by contamination from an inactivated coronavirus vaccine. The researchers assessed 346 clinical samples and 132 environmental samples, evaluating the assay's amplification efficiency, precision, and lower limit of detection. Together, these reports show that vaccine contamination can complicate interpretation of PCR-based testing when clinical or environmental samples are involved.